Obese youth with leukemia more likely to have persistent disease

Following induction chemotherapy, obese patients were more than twice as likely to have minimal residual disease, than non-obese patients, new research suggests. "Induction chemotherapy provides a patient's best chance for remission or a cure," said the principal investigator. "Our findings indicate that a patient's obesity negatively impacts the ability of chemotherapy to kill leukemia cells, reducing the odds of survival."

Read the whole article on Science Daily

More from Science Daily